1. Home
  2. TGNA vs ARQT Comparison

TGNA vs ARQT Comparison

Compare TGNA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TGNA
  • ARQT
  • Stock Information
  • Founded
  • TGNA 1906
  • ARQT 2016
  • Country
  • TGNA United States
  • ARQT United States
  • Employees
  • TGNA N/A
  • ARQT N/A
  • Industry
  • TGNA Broadcasting
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TGNA Industrials
  • ARQT Health Care
  • Exchange
  • TGNA Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • TGNA 3.2B
  • ARQT 3.3B
  • IPO Year
  • TGNA N/A
  • ARQT 2020
  • Fundamental
  • Price
  • TGNA $19.64
  • ARQT $30.97
  • Analyst Decision
  • TGNA Buy
  • ARQT Strong Buy
  • Analyst Count
  • TGNA 4
  • ARQT 7
  • Target Price
  • TGNA $20.00
  • ARQT $22.17
  • AVG Volume (30 Days)
  • TGNA 1.7M
  • ARQT 2.7M
  • Earning Date
  • TGNA 11-10-2025
  • ARQT 10-28-2025
  • Dividend Yield
  • TGNA 2.56%
  • ARQT N/A
  • EPS Growth
  • TGNA N/A
  • ARQT N/A
  • EPS
  • TGNA 2.10
  • ARQT N/A
  • Revenue
  • TGNA $2,876,414,000.00
  • ARQT $317,929,000.00
  • Revenue This Year
  • TGNA N/A
  • ARQT $85.27
  • Revenue Next Year
  • TGNA $5.99
  • ARQT $30.70
  • P/E Ratio
  • TGNA $9.29
  • ARQT N/A
  • Revenue Growth
  • TGNA N/A
  • ARQT 129.21
  • 52 Week Low
  • TGNA $14.87
  • ARQT $10.57
  • 52 Week High
  • TGNA $21.35
  • ARQT $31.11
  • Technical
  • Relative Strength Index (RSI)
  • TGNA 44.96
  • ARQT 75.88
  • Support Level
  • TGNA $18.83
  • ARQT $27.08
  • Resistance Level
  • TGNA $20.07
  • ARQT $31.10
  • Average True Range (ATR)
  • TGNA 0.27
  • ARQT 1.59
  • MACD
  • TGNA -0.03
  • ARQT 0.50
  • Stochastic Oscillator
  • TGNA 58.63
  • ARQT 98.36

About TGNA TEGNA Inc

Tegna Inc is a media company with a portfolio of broadcast stations and digital sites. The firm has television stations and radio stations in approximately U.S. markets. The company owns multicast networks of True Crime Network, Twist, and Quest. Each television station also has a robust digital presence across online, mobile, connected television, and social platforms, reaching consumers on all devices and platforms used to consume news content. It generates key revenue from advertising and marketing services, subscriptions, political advertising, and other services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: